STAG1

Chr 3AD

STAG1 cohesin complex component

Also known as: MRD47, SA1, SCC3A

This gene is a member of the SCC3 family and is expressed in the nucleus. It encodes a component of cohesin, a multisubunit protein complex that provides sister chromatid cohesion along the length of a chromosome from DNA replication through prophase and prometaphase, after which it is dissociated in preparation for segregation during anaphase. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.121 OMIM phenotype
Clinical SummarySTAG1
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
57 unique Pathogenic / Likely Pathogenic· 300 VUS of 698 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.12LOEUF
pLI 1.000
Z-score 7.69
OE 0.05 (0.030.12)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
4.44Z-score
OE missense 0.51 (0.470.56)
338 obs / 658.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.05 (0.030.12)
00.351.4
Missense OE?0.51 (0.470.56)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 4 / 76.7Missense obs/exp: 338 / 658.9Syn Z: -0.89
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSTAG1-related syndromic intellectual disabilityLOFAD

This gene — mechanism propensity

DN
0.3196th %ile
GOF
0.4085th %ile
LOF
0.69top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 67% of P/LP variants are LoF · LOEUF 0.12 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFFunctional studies of the variants and studies of patient cells were not performed, but Lehalle et al. (2017) postulated that the neurodevelopmental phenotype is caused by STAG1 haploinsufficiency with a putative disruptive effect on transcriptional regulation.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 28119487

ClinVar Variant Classifications

698 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic40
VUS300
Likely Benign248
Benign36
Conflicting22
17
Pathogenic
40
Likely Pathogenic
300
VUS
248
Likely Benign
36
Benign
22
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
14
1
2
0
17
Likely Pathogenic
24
15
1
0
40
VUS
5
270
21
4
300
Likely Benign
0
24
113
111
248
Benign
0
5
23
8
36
Conflicting
22
Total43315160123663

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

25 pathogenic / likely-pathogenic (of 34) ClinVar copy-number / structural variants overlap STAG1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

STAG1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.